⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 2025Open Access

Advocating for Hope, Access, and Future in Rare and Paediatric Cancer Patients

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to advocate for better access to therapies and support for patients with rare and paediatric cancers.
Analyzed current access issues in therapies for rare and paediatric cancers.
Evaluated advocacy strategies for improving health equity.
Reviewed relevant literature and case examples.
Identified significant barriers to therapy access for rare cancer patients.
Reported a need for policy changes to improve equity in healthcare access.
Highlighted successful advocacy efforts that led to improved outcomes for patients.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Advocating for improved access to therapies for rare and paediatric cancer patients, suggesting enhanced health equity.

Abstract

-

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ana Pataki (2025) studied this question.

synapsesocial.com/papers/69f04e30727298f751e721ec https://doi.org/10.66552/oi2025201

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Abstract 1287: The ACCESS consortium: Advancing childhood cancer experience, science and survivorship in Canada2024 · 1 citations
2Abstract IA026: Are we ready to accelerate the development of new safe and effective anticancer medicines for children and adolescents?2024
3Abstract B069: ACCESS: Advancing childhood cancer experience, science and survivorship in Canada2024
4Abstract IA002: Challenges in accessing innovation for children with cancer2025
5Impact of precision oncology research in pediatric poor prognosis cancer: patient, parent and healthcare provider perspectivesOriginal Research · 2026
6SP9 Impact of compassionate access to targeted therapies in paediatric cancer a pharmacy perspective2024
7‘High hopes for treatment’: Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases2024 · 5 citations
8Abstract A024: Insights across indications from the Pediatric Bespoke Therapeutic Development Workshop initiative2025

More from University of Novi Sad